PEGylated recombinant human interferon alpha-2b injection
LCYJ2021ZD006
Phase 1 small_molecule active
Quick answer
PEGylated recombinant human interferon alpha-2b injection for Hepatitis B, Chronic is a Phase 1 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Hepatitis B, Chronic
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active